LoginSignup
profile image
Dennis
@GordonGekko83
2Mon·

Who of you is invested in $EUZ (+1.36%) and what do you think of the IPO of Pentixapharm?


Are you selling after the IPO or are you holding on to both companies?


$EUZ (+1.36%) Pentixapharm produces radioisotopes for medical applications, etc.


Pentixapharm, on the other hand, concentrates on the production of radiopharmaceuticals for the diagnosis and treatment of diseases, particularly cancer.


I personally find both companies interesting and will continue to hold both.

5
4 Comments
profile image
Brian@TherealBFS
2Mon
Here I have an interesting video where Andreas explains what Eckert und Ziegler does and why the spin-off from Pentixapharm is being made. I haven't yet thought about whether I will keep them, but in general I find the area of application interesting.

The video: https://www.biotechtv.com/post/eckert-and-ziegler-september-9-2024

I would also like to buy more Eckert and Ziegler, but unfortunately it is still a bit too expensive for me. I only have a mini position that I would like to expand.
•
2
•
profile image
news03@user03
2Mon
I am invested and currently still undecided, to be honest I would have liked it better if they didn't do an IPO. But will probably hold both or sell pentixapharm if they do, no advice :)
•
1
•
profile image
ZeissJessy@ZeissJessy
2Mon
This means that each shareholder will receive one Pentixapharm share for each Eckert & Ziegler share.
•
1
•
profile image
finanzperpetuum@finanzperpetuum
2Mon
•
1
•
Join the conversation
Sign upLogin